RadNet, Inc. (RDNT)
NEGATIVEFundamental
35
मूल्य
$76.22
मार्केट कैप
$5.92B
भाग 1 · कंपनी का मूल्य कितना है
अवलोकन
RadNet, Inc., together with its subsidiaries, provides outpatient diagnostic imaging services in the United States and internationally. The company operates in two segments, Imaging Centers and Digital Health. Its services include magnetic resonance imaging, computed tomography, positron emission tomography, nuclear medicine, mammography, ultrasound, diagnostic radiology, fluoroscopy, and other related procedures, as well as multi-modality imaging services. The company also develops and sells computerized systems that distribute, display, store, and retrieve digital images; picture archiving communications systems and related services; and develops and deploys AI suites to enhance radiologist interpretations of breast, lung, and prostate images, as well as solutions for prostate cancer screening. In addition, it develops and delivers AI-powered health informatics solutions to drive quality, efficiency, and outcomes in imaging and radiology; informatics designed for outpatient radiology; and DeepHealth OS, a cloud-native operating system that helps in the operations of the radiology service. RadNet, Inc. was founded in 1981 and is headquartered in Los Angeles, California.
No editorial profile for this company yet
Direct competitors
Who this company fights with for the same customers
No editorial profile for this company yet
No competitor list for this company yet.
बैलेंस शीट और तरलता
राजस्व
$2.27B
पिछले 12 महीने (30/6/2026 तक)
शुद्ध आय
$-21M
पिछले 12 महीने (30/6/2026 तक)
Free Cash Flow
-
कुल इक्विटी
$1.09B
कुल देनदारियाँ
$2.40B
Current Ratio
1.48
Interest Coverage
0.99
Debt/EBITDA
10.20
Earnings Per Share
राजस्व और शुद्ध आय
Free Cash Flow
आय विवरण
ऐतिहासिक विवरण
समय के साथ मार्जिन
समय के साथ ऋण
ऋण कितना भारी है
वृद्धि तालिका
वृद्धि — राजस्व
Fair Value अनुमान
Fair Value
$52.45
वर्तमान मूल्य
$76.22
Margin of Safety
-45.3%
Fair Value सीमा
$34.09 - $70.81
अनुमान विधियाँ
मूल्यांकन मेट्रिक्स
P/E Ratio
-
ROE
-1.7%
P/B Ratio
5.36
P/FCF
-
Gross Margin
-
ROIC
1.6%
लाभप्रदता Radar
Value Creation (Economic Moat)
ROIC
1.6%
WACC
9.7%
ROIC − WACC
-8.1 pp
ROIC is below the cost of capital — the company is destroying value for every dollar invested.
Fundamental विश्लेषण मानदंड
पास (6)
- Price CAGR 28.12%
- Debt/Equity ratio
- Current Ratio
- Revenue Growth 5Y 13.7%
- Analyst Consensus 93% Buy
- Earnings Surprise avg 13.4%
फेल (13)
- EPS shows upward trend
- ROIC 1.6%
- P/B Ratio 5.36
- Operating Margin 3.1%
- Interest Coverage
- Debt/EBITDA
- Return on Tangible Assets
- Low reliance on intangibles
- DCF valuation (Overvalued)
- ROE -1.4%
- Share Dilution 6.8%
- Net Margin Trend -0.9% vs -0.8%
- Piotroski F-Score 3/9
अनुपलब्ध (8)
- Gross Margin NaN%
- P/FCF NaN
- Dividend Payout NaN%
- Positive Free Cash Flow
- CapEx intensity
- Price below Graham Number
- PEG Ratio (need PE > 0 and growth > 0)
- Earnings Quality (OCF/Net Income)
Piotroski F-Score
गंभीर वित्तीय चिंताएं
Earnings गुणवत्ता
निम्न गुणवत्ता: accounting की जांच करें
शेयर Dilution
नए शेयर जारी कर रही है, स्वामित्व को कम कर रही है
प्रशासन
कार्यकारी टीम
| नाम | पद | आयु |
|---|---|---|
| Dr. Howard G. Berger M.D. | Chairman, President & CEO | 79 |
| Mr. Mark D. Stolper | Executive VP & CFO | 54 |
| Mr. Mital Patel | Executive VP & COO | 39 |
| Mr. Norman R. Hames | President & CEO of Western Operations | 69 |
| Mr. Stephen M. Forthuber | President & CEO of Eastern Operations | 64 |
| Dr. Alma Gregory Sorensen M.D. | Executive VP, Chief Strategy Officer & Director | 63 |
| Ms. Susan Hollabaugh | Chief Information Officer | - |
| Mr. David Jeffrey Katz Esq. | Executive VP, Chief Legal Officer & Corporate Secretary | 61 |
| Mr. David Manheim | Senior VP & Chief Compliance Officer | - |
| Mr. Michael M. Murdock | Executive Vice President of Mergers & Acquisitions | 70 |
Audit जोखिम
8
बोर्ड जोखिम
8
मुआवजा जोखिम
7
शेयरधारक अधिकार जोखिम
2
भाग 2 · कीमत और खरीदने का समय
यह हिस्सा यह नहीं बताता कि कंपनी अच्छी है या नहीं: यह तय करने में मदद करता है कि उसे कब खरीदें, जब फंडामेंटल आपको आश्वस्त कर चुके हों। इसमें: तकनीकी विश्लेषण, संभावना, ऐतिहासिक गिरावट, गामा एक्सपोज़र।
Latest News
Recent headlines for RDNT, sourced from Markets Gazette.
- 3/2/2026NEUTRALRadNet (RDNT) Q4 2025 Earnings Call Transcript
The transcript for RadNet Inc.'s (RDNT) Q4 2025 earnings call is now available to investors. While access to such documents is crucial for understanding the company's financial performance and future outlook, the current lack of specific content details prevents an immediate assessment of market impact. Analysts and investors are awaiting a review of key data, management statements, and projections to evaluate RadNet's operational and strategic health. Earnings calls are pivotal moments for grasping growth trends, profit margins, and any potential challenges the company might face in the diagnostic imaging services sector. Without the content, the signal remains neutral, pending further insights.
- 3/2/2026NEUTRALRadNet Earnings Review: Q4 Summary
Markets Gazette notes the announcement of RadNet's Q4 earnings review. While the title suggests an upcoming analysis of the company's financial performance, the provided article lacks specific details regarding the results, such as revenue figures, earnings per share, or future projections. This absence of concrete data prevents investors from assessing RadNet's current financial health or anticipating potential market movements. Traders are eagerly awaiting further information to formulate informed investment strategies.
via Markets Gazette